Fennel

What is Fennel?

Fennel tea has not been recommended for children under 4 by the European Medicines Agency's herbal committee (HMPC) since its July 2007 monograph on sweet fennel fruit, and in January 2024 the committee added a numeric estragole limit for children 4 to 12. That limit exists because the dried fruit of Foeniculum vulgare Mill., the seed in every fennel tea bag, carries estragole, which the same committee describes as a naturally occurring genotoxic carcinogen.

Fennel is a tall perennial of the carrot family, Apiaceae, native to the Mediterranean. Three different things come from it. The swollen leaf base sold in produce aisles is Florence fennel, a vegetable usually classed as var. azoricum. The dried ripe fruit is the spice and the medicine, and it comes in two pharmacopeial grades: bitter fennel (var. vulgare), which carries more essential oil and the camphor-like ketone fenchone, and sweet fennel (var. dulce), which carries less oil, little fenchone and a sweeter, anise-like taste. The third is the essential oil steam-distilled from either fruit. A baby tea, a nursing tea and a capsule can all say "fennel" while delivering very different chemistry.

Common Names

• Fennel, fennel seed (botanically a fruit), saunf (Hindi), finocchio (Italian)

• Bitter fennel, common fennel: F. vulgare Mill. subsp. vulgare var. vulgare; Foeniculi amari fructus in pharmacopeial Latin

• Sweet fennel, Roman fennel: F. vulgare Mill. subsp. vulgare var. dulce (Mill.) Batt. & Trab.; Foeniculi dulcis fructus

• Florence fennel, bulb fennel: the vegetable

• Methyl chavicol: an older name for estragole that sometimes appears on essential oil certificates instead

Primary Active Compounds

• trans-Anethole, the dominant constituent of the oil and the source of the licorice-like taste. The European Pharmacopoeia requires at least 60.0 percent in bitter fennel oil and at least 80.0 percent in sweet, as summarized in the EMA's 2024 assessment report.

• Fenchone, a monoterpene ketone: at least 15.0 percent of the oil in bitter fennel, far less in sweet

• Estragole (1-allyl-4-methoxybenzene), the genotoxic constituent. The HMPC's estragole statement, using figures modified from EFSA in 2009, lists it at 3.5 to 12.0 percent of bitter fennel oil and 1.5 to 5.0 percent of sweet fennel oil.

• Limonene and smaller terpenes

• Nonvolatile phenolics, including chlorogenic and neochlorogenic acids, and flavonoid glycosides

Key Note

The essential oil sits inside the fruit, and a tea extracts only part of it. Van den Berg and colleagues at Wageningen University tested 37 fennel-based products and found that infusions captured from under 0.1 to 2.5 percent of the estragole in the dry material, and infusions of whole fruit carried about one third as much estragole as infusions of finely cut fruit (Food and Chemical Toxicology 2014;65:147). How the fruit is cut, how long it steeps and whether the bag is squeezed decide how much estragole reaches the cup, and none of those variables appears in a supplement facts panel.

Fennel is a kitchen spice, a European traditional medicine with age limits, and, on the US labels reviewed for this issue, a nursing tea with none of those limits printed.

Scan any fennel product in seconds with the free NutrientWise app: App Store · Google Play

Primary Functions & Benefits

Fennel fruit has three uses that a European regulator accepts on the basis of long-standing use, one infant use with randomized trials that regulators have not accepted, and a lactation reputation with weak trials.

What the EU monograph covers

The HMPC's revised monograph on bitter fennel fruit (EMA/HMPC/372841/2016, Revision 1, adopted 31 January 2024) lists three traditional-use indications: relief of mild, cramp-like digestive complaints including bloating and flatulence; relief of minor spasm with menstrual periods; and an expectorant for cough with colds. "Traditional use" means the product has been on the European market long enough (at least 30 years, 15 of them in the EU) for the committee to judge it plausible and safe at the stated dose. It is not a finding of efficacy from trials. The monograph names no infant indication and does not recommend use under 4 for any purpose.

Infant colic: fennel's own trials

The colic evidence that exists for fennel does not come from teas sold in shops. It comes from three small trials of specific preparations.

• Alexandrovich and colleagues, St Petersburg Medical Academy of Postdoctoral Education (Alternative Therapies in Health and Medicine 2003;9:58): a fennel seed oil emulsion against placebo in 125 infants 2 to 12 weeks old meeting the Wessel definition of colic, with the result reported on 121. The abstract gives an absolute risk reduction of 41 percent (95 percent CI 25 to 57) and a number needed to treat of 2, and says no side effects were reported in either arm. The abstract does not state the emulsion's oil concentration, which is exactly the variable estragole exposure depends on.

• Savino and colleagues, Regina Margherita Children's Hospital, Turin (Phytotherapy Research 2005;19:335): ColiMil, a combined extract of chamomile, fennel and lemon balm, given twice daily to breastfed infants. Crying time fell in 85.4 percent of the extract group against 48.9 percent on placebo (p < 0.005), among the 88 of 93 enrolled infants who finished the week. Fennel was one of three herbs, and a later mouse study by Capasso and Savino found the fennel component alone did not slow gut transit while the chamomile and lemon balm components did (Phytotherapy Research 2007;21:999).

• Weizman and colleagues, Soroka Medical Center, Beer-Sheva (Journal of Pediatrics 1993;122:650): an herbal tea described in later reviews as chamomile, vervain, licorice, fennel and balm-mint. Colic was eliminated in 19 of 33 infants on tea (57 percent) and 9 of 35 on placebo (26 percent). A 2006 Journal of Family Practice review judged that "the volume necessary for treatment limits its usefulness," and every milliliter of tea is a milliliter of milk not taken.

Harb and colleagues pooled three fennel-containing preparations in a 2016 meta-analysis in the Journal of Pediatric Gastroenterology and Nutrition and found crying reduced by 72.1 minutes a day (95 percent CI 17.7 to 126.4). Perry, Hunt and Ernst's 2011 review in Pediatrics (15 trials of complementary treatments) called the fennel extract and mixed herbal tea results "encouraging" and stressed that every trial had major limitations. None of the three trials tested a plain fennel tea bag, and none measured estragole.

What fennel is not shown to do

The estrogen-like activity of anethole is a hazard in this issue, not a benefit; it is the likely reason fennel has been linked to breast development in young girls (see Potential Negatives).

Forms & Standardization

Fennel is sold in at least seven forms, and the estragole a person actually swallows varies by more than a thousandfold across them.

Whole dried fruit, bitter or sweet

The pharmacopeial material. As summarized in the EMA's 2024 assessment report (EMA/HMPC/240553/2016 Rev 1), the European Pharmacopoeia requires bitter fennel to yield at least 40 mL of essential oil per kg of anhydrous fruit, with at least 60.0 percent anethole and 15.0 percent fenchone in that oil, and sweet fennel at least 20 mL per kg, with at least 80.0 percent anethole. Bitter fennel is the stronger, oilier drug and the one with the higher estragole range in the HMPC's table (3.5 to 12.0 percent of the oil against 1.5 to 5.0 for sweet). Real batches move around: a bitter fennel lot supplied for a 2026 toxicology study at RPTU Kaiserslautern-Landau held 5.91 percent oil, of which estragole was 2.9 percent, anethole 71.7 and fenchone 19.0 (Ackermann and colleagues, Archives of Toxicology 2026;100:3173). Whole fruit releases far less estragole into hot water than cut fruit.

Cut or crushed fruit in teabags

The common retail form. Traditional Medicinals' Organic Fennel lists 2,000 mg of organic fennel fruit per bag, describes its source as medicinal-quality bitter fennel, and directs one bag steeped 10 to 15 minutes, covered, then squeezed, 1 to 3 cups a day. Austrian researchers found that squeezing the bag and using broken fruit both raised estragole in the cup (Mihats and colleagues, International Journal of Food Sciences and Nutrition 2017;68:569, as summarized by the HMPC). The same team measured 3 to 8.5 percent essential oil in bitter fennel teas and 0.8 to 3 percent in sweet, and an average of 565 µg of estragole per liter of teabag infusion, with a maximum of 2,477 µg/L, about 620 µg in a 250 mL cup and above Raffo's highest value (as summarized in the EMA's 2024 assessment report). The Organic Fennel ingredient line itself says only "organic fennel fruit."

Instant (granulated) fennel teas

Powders of dried aqueous extract, marketed for infants in Europe. Their estragole content is inconsistent between surveys. Raffo's group measured 9 to 912 µg per liter in diluted instant teas and flagged that "these products are designed for infant consumption"; the Austrian survey of 42 teas found no estragole in the instant products it tested. Raffo's group concluded that wider use of suitable production technologies could substantially cut the estragole in instant teas.

Multi-herb lactation teas

Traditional Medicinals' Organic Mother's Milk is the reference product: per bag, 560 mg bitter fennel fruit, 350 mg anise fruit, 210 mg coriander fruit, 35 mg fenugreek seed, 35 mg blessed thistle and a 560 mg blend of spearmint, lemongrass, lemon verbena and marshmallow root. Directions: 8 oz of boiled water, cover, steep 10 minutes, squeeze, 3 to 5 cups a day. That is 1.68 to 2.8 g of bitter fennel daily. Anise oil is itself 87 to 94 percent anethole (Murphy and colleagues, Plants 2024), so the fennel figure alone understates the anethole in each cup.

Infant colic preparations

Multi-herb products (ColiMil in Italy, a fennel-based product called BabyCalm in Israel, Digas Colic Drops with caraway, fennel, two mints and ginger in Pakistan) and US gripe waters that list fennel extract in milligram amounts. None of the product descriptions found for this issue states an estragole content.

Fennel essential oil

Steam-distilled from bitter or sweet fruit. Here estragole is not a trace: at 3.5 to 12 percent of bitter fennel oil, every gram of oil carries 35 to 120 mg of it, against the HMPC's 0.05 mg daily guidance for adults. Fennel oil is sold for aromatherapy, flavoring and topical use. It is not an oral supplement for anyone, and never for a child.

Capsules and powders

Ground fennel seed and branded "fennel extract" capsules. Iranian dysmenorrhea trials used a fennel extract and a 30 mg soft capsule of undisclosed standardization (details in Special Considerations). A capsule that states no anethole or estragole content cannot be matched to any trial preparation.

Food Sources

Fennel is a food twice over, and neither food form is where the regulatory concern sits.

Florence fennel bulb, raw, per 100 g (USDA FoodData Central, Foundation Foods, FDC 2747655)

26.9 kcal, 92.6 g water, 2.05 g fiber, 332 mg potassium, 14.7 mg vitamin C, 41.3 mg calcium and 37 µg folate. A useful, watery vegetable; nobody's potassium or vitamin C status hinges on it, and the HMPC and EFSA estragole assessments cited in this issue were built on fruit preparations, not the bulb.

Fennel seed, per 100 g (USDA Standard Reference 28, as reproduced by the Norwegian Food Composition Table)

327 kcal, 15.8 g protein, 14.9 g fat, 40 g fiber, 1,196 mg calcium, 18.5 mg iron, 385 mg magnesium, 1,694 mg potassium and 21 mg vitamin C. At kitchen amounts the numbers shrink: 2 g of seed, about what one Traditional Medicinals bag holds, carries roughly 24 mg of calcium and 0.37 mg of iron, and a tea extracts only part of that.

Background estragole from the rest of the diet

The HMPC cites earlier estimates of 0.5 to 5 mg of estragole a day from food in general and a Council of Europe figure of about 1 mg per person per day. That is already above the 0.05 mg guidance value the committee set, and the guidance applies to what a medicinal product adds on top of that diet. Basil, tarragon and star anise oils are far richer in estragole than fennel oil (20 to 89, 60 to 75 and 5 to 6 percent respectively, per figures Ackermann's group took from the HMPC). EU flavoring law already bars adding estragole as such to food, and caps it at 50 mg/kg in several food categories and 10 mg/kg in non-alcoholic beverages when it arrives with flavorings, as summarized in a 2025 UK Committee on Toxicity paper.

Is diet sufficient?

There is no requirement to meet. A fennel seed sprinkled on bread or chewed after a meal is food. A daily therapeutic tea is a medicinal exposure and is assessed as one.

Who Should Take Fennel

No infant, toddler, pregnant woman or breastfeeding mother should take fennel as a medicine on the strength of current evidence and regulatory positions. The adults for whom a short course is defensible are narrow.

Adults with mild, uncomplicated bloating or cramping digestive discomfort

This is the traditional-use indication in the EU monograph, at regulated amounts and for no more than 2 weeks. Anyone whose symptoms are new, persistent, nocturnal, or accompanied by weight loss, blood or vomiting needs evaluation, not tea.

Adult and adolescent women with primary dysmenorrhea

Menstrual cramps are an EU traditional-use indication for those 12 and older, and the trial evidence is better here than for most fennel uses (see Benefits). It is a reasonable short trial for someone who cannot take an NSAID and is not pregnant or trying to conceive.

Who should be steered elsewhere

• Parents of a crying baby. The HMPC does not recommend fennel tea under age 4, and the colic trials tested specific products, not tea.

• Breastfeeding mothers seeking more milk. The EU monograph does not recommend fennel during lactation, and a feeding assessment addresses the usual causes of low supply.

• Anyone wanting an estrogen-like effect for menopause. Fennel's estrogenic activity is a safety signal in this issue, not a validated treatment.

Who Should AVOID or Use Caution

Contraindications

• Children under 4. "The use is not recommended in children under 4 years of age due to lack of adequate data" (EU monograph, bitter fennel fruit, 2024). The same position appeared in the 2007 sweet fennel monograph.

• Pregnancy and breastfeeding. The 2024 monograph states that "in the absence of sufficient data, the use during pregnancy and lactation is not recommended," and notes that trans-anethole is excreted in breast milk. The estragole statement separately sets 50 µg a day as the ceiling above which use in these women is not recommended. EFSA's July 2025 draft opinion on fennel fruit preparations went further: its draft conclusion is that intake during pregnancy and lactation "may pose health risks to both the unborn child and the newborn."

• Fennel essential oil taken by mouth, at any age, and any application of it to infants.

• Allergy to fennel, other Apiaceae (aniseed, caraway, celery, coriander, dill) or anethole, and sensitization to mugwort pollen, which the EU monograph lists as a cross-reactivity contraindication.

• Epilepsy, for the essential oil and concentrated extracts (see Toxicity).

Use Caution

• Girls before puberty with any breast development. Ask specifically about fennel tea; two published case reports tie it to premature thelarche (see Potential Negatives).

• Estrogen-sensitive conditions, including a history of hormone-receptor-positive breast cancer or endometriosis. The estrogenic data are from rodents and isolated anethole, not from human outcome studies, so this caution is theoretical.

• Oral ciprofloxacin and other quinolone antibiotics, which a fennel extract cut sharply in a rat study (see Interactions).

Critical Safety Point

The group most often given fennel tea for colic is the group the EU monograph excludes outright. The HMPC has not recommended fennel tea under 4 since 2007; the 2024 revision limits children 4 to 12 by their estragole intake; Raffo's measurements put infant intakes from teabag tea up to 51 times the HMPC's children's guidance value; and a PubMed search on 26 October 2026 returned two case reports of premature breast development linked to fennel, both in young girls, one of them a 12-month-old given fennel tea daily. A baby who cries a great deal, feeds poorly, vomits, or has a fever needs to be seen. A fennel tea does not address any of those, and it adds an estragole exposure that both the HMPC and EFSA's 2025 draft treat as one to avoid in the very young.

Recommended Dosages

There is no recommended dose of fennel in any form for infants, children under 4, or pregnant or breastfeeding women. The only figures below are the EU monograph's traditional-use posology for herbal tea.

Children under 4, and anyone pregnant or breastfeeding

None. The 2024 monograph does not recommend use, and the estragole statement sets intake ceilings these groups have no practical way to verify from a US label.

Children 4 to 12 (bitter fennel tea)

The monograph gives 1.0 g of fruit in 100 mL of boiling water, steeped 15 minutes, three times daily (3.0 g a day), for digestive complaints or cough only, for under a week, and with a condition attached: not recommended if the child's estragole intake would exceed 1.0 µg per kg of body weight a day. For a 20 kg child that is 20 µg, about what 80 mL of tea holds at the bottom of Raffo's teabag range. None of the US labels reviewed for this issue states an estragole content, so a parent has no way to check the condition, which in practice leaves no verifiable dose.

Adults and adolescents over 12 (bitter fennel tea)

1.5 g of fruit in 250 mL of boiling water, steeped 15 minutes, three times daily (4.5 g a day), for no more than 2 weeks. The superseded 2007 sweet fennel monograph allowed 1.5 to 2.5 g three times daily. A single 2 g Traditional Medicinals bag already exceeds one monograph dose, and the label's 3-cup maximum (6 g) exceeds the monograph's daily total by a third.

Fennel essential oil

No oral amount is given here for anyone.

Capsules, powders and extracts

No regulator has set a dose for the unstandardized capsules sold in the US. The preparations used in trials are listed under Special Considerations so they are not read as directions.

Duration

Two weeks for adults under the monograph; under one week for children 4 to 12. Controlled human exposures found for this issue ran from 1 week (infant colic) to 6 months (a fennel infusion combined with cupping, tested against metformin for infrequent periods in polycystic ovary syndrome); the Mother's Milk safety trial ran 30 days.

Timing & Administration

Whole fruit, not cut, if fennel tea is used at all. Van den Berg's group found whole-fruit infusions carried about a third of the estragole of finely cut material. The superseded 2007 monograph specified freshly comminuted fruit; crushing releases more oil, and with it more estragole.

Do not squeeze the bag. The Austrian survey linked squeezing to higher estragole, and both Traditional Medicinals labels reviewed for this issue tell the user to squeeze.

Separate from ciprofloxacin. Zhu and colleagues at the Chinese University of Hong Kong, who found the interaction in rats, advised an adequate dosing interval if the two are used together. No human study has defined the interval.

For menstrual cramps, the trial regimen started before the pain. In Ghodsi and Asltoghiri's trial the capsules began 3 days before menstruation and continued to day 5.

Timeline of Effects

Digestive discomfort. The monograph frames fennel tea as relief for mild, transitory symptoms. If bloating or cramping has not settled within the 2-week adult limit, the tea has not worked and the symptom needs a diagnosis.

Infant colic, in the trials. ColiMil's effect was measured over 1 week of twice-daily dosing. Colic peaks in the first 6 weeks and usually resolves by 3 months (per the 2018 Cochrane review by Gordon and colleagues), so any uncontrolled impression of improvement over weeks is confounded by the condition's own course.

Dysmenorrhea. Modaress Nejad and Asadipour followed girls for 2 months; Ghodsi and Asltoghiri's trial ran 3 cycles, with menstrual duration differing from control only after 2 and 3 months. Two to three cycles is a fair trial; no change by then is an answer.

Milk supply. Studies summarized by LactMed ran 10 days to 4 weeks. The uncontrolled study of 5 mothers reported volume and fat rising somewhat during 10 days of fennel infusion.

Adverse effects run on their own clock. In Okdemir and colleagues' 2014 case, breast development appeared after about 3 months of daily fennel tea in a girl who had been drinking it for 6, and took about a year to regress after the tea was stopped. In the two newborns reported by Rosti and colleagues in 1994, lethargy and poor feeding resolved within 24 to 36 hours of stopping the mothers' tea and breastfeeding. Estragole's DNA effects, by contrast, have no symptom timeline at all.

Benefits of Taking Fennel

Menstrual cramps: the best-supported adult use

Modaress Nejad and Asadipour randomized high-school girls in Kerman, Iran (mean age 13) to a fennel extract (n = 55) or mefenamic acid (n = 55) for 2 months in 2002. Pain decreased or resolved in 80 percent on fennel and 73 percent on the drug, with no significant difference between groups (Eastern Mediterranean Health Journal 2006). Two meta-analyses followed. Lee and colleagues at the Korea Institute of Oriental Medicine reviewed 12 trials (Nutrients 2020): against conventional drugs, the standardized mean difference was 0.07 (95 percent CI minus 0.08 to 0.21, 502 women), meaning no detectable difference; against placebo it was minus 3.27, with heterogeneity of 98 percent, a figure that signals trials disagreeing too much to pool cleanly. Only 3 of the 12 assessed adverse events, and the authors flagged likely publication bias. Shahrahmani and colleagues (Journal of Complementary and Integrative Medicine 2021) reported a smaller placebo-controlled effect (SMD minus 0.632 across seven trials) and no difference from mefenamic acid. The individual trials named here are Iranian, small and short.

Milk supply: weak and mixed

NIH's LactMed record for fennel (as mirrored by Drugs.com, updated 10 August 2025) summarizes the evidence. An uncontrolled study of 5 mothers saw modest rises in milk volume and fat. A randomized trial by Turkyılmaz and colleagues gave 22 of 66 mothers a commercial galactagogue tea containing fenugreek; pumped milk on day 3 was higher and their infants regained birth weight sooner, but the tea held several herbs. In an uncontrolled study of 46 Iranian mothers, serum prolactin rose from about 64.6 to 95.6 µg/L after 15 days of 3 g of powdered fennel a day, while a controlled syrup trial (fennel 3 g with honey and frankincense, n = 35, against the same syrup without fennel, n = 34) found no between-group difference in prolactin. LactMed's summary says no rise in serum prolactin has been found in nursing mothers, despite the uncontrolled Iranian result, and that a galactagogue should not replace an evaluation of why supply is low.

Infant colic

Covered in Primary Functions: three small positive trials of specific preparations (an oil emulsion, a three-herb extract and a five-herb tea), none of them a retail fennel tea, and the HMPC still recommends against fennel under 4.

Digestive comfort in adults

The EU monograph's traditional-use indication. It rests on long use, not on placebo-controlled trials of fennel tea, and the author found none to cite.

Potential Negatives & Side Effects

Premature breast development in young girls

Two reports are indexed in PubMed. Türkyılmaz and colleagues at Gazi University's pediatric surgery department in Ankara titled theirs "A striking and frequent cause of premature thelarche in children: Foeniculum vulgare" (Journal of Pediatric Surgery 2008;43:2109). Its abstract links long-term use of fennel preparations given for gas to isolated premature thelarche and says such use "should be limited"; it does not state the number of children. Okdemir and colleagues (Journal of Pediatric Endocrinology and Metabolism 2014;27:175) described a 12-month-old girl whose mother had given her two to three teaspoons of fennel tea daily for 6 months for restlessness. Breast development had become apparent over the previous 3 months; laboratory findings fit isolated premature thelarche; after the tea was stopped, it regressed gradually and was normal within a year. Case reports cannot establish frequency or prove cause, but the regression on stopping is the pattern expected of an external estrogen-like exposure.

Two newborns poisoned through breast milk

Rosti and colleagues (Acta Paediatrica 1994), as summarized by LactMed, described infants aged 15 and 20 days admitted with poor weight gain, lethargy, weak suck, vomiting, a weak cry and low muscle tone. Each mother had been drinking more than 2 liters a day of an herbal tea reportedly containing licorice, fennel, anise and goat's rue. Symptoms cleared within 24 to 36 hours of stopping the tea and breastfeeding, and both infants were well at 6 months. The authors blamed anethole; neither the milk nor the tea was analyzed.

Seizures from the essential oil

Skalli and Soulaymani Bencheikh, of Morocco's national pharmacovigilance center, reported a 38-year-old woman with previously well-controlled epilepsy on lamotrigine who had a generalized tonic-clonic seizure, unconscious for 45 minutes, after eating cakes made with an unknown quantity of fennel essential oil (Epileptic Disorders 2011;13:345). Burkhard and colleagues at Geneva University Hospital listed fennel among 11 essential oils known as convulsants, attributing the effect to reactive monoterpene ketones including fenchone (Journal of Neurology 1999).

Allergy

The EU monograph lists allergic reactions of the skin or respiratory tract, frequency unknown, and contraindicates fennel in people sensitized to mugwort pollen or other Apiaceae.

Other reported effects

LactMed lists photosensitivity among maternal side effects, plus two single cases: diarrhea and liver enlargement in a woman taking fennel, fenugreek and goat's rue, and raised liver enzymes in a woman drinking Mother's Milk tea, and an Australian survey of 157 breastfeeding mothers found about 4 percent reporting adverse reactions, mainly nausea and stomach cramps. The industry-coauthored Mother's Milk trial (60 exclusively breastfeeding mothers randomized to the tea or a lemon verbena placebo for 30 days, Wagner and colleagues, Journal of Human Lactation 2019) found no adverse effects attributable to either tea through the infants' first year. One of its eight authors was employed by Traditional Medicinals.

Deficiency Symptoms

What fennel addresses

Nothing. Anethole, fenchone and estragole have no nutritional role, and no deficiency state results from never eating fennel.

Bottom line

The minerals in fennel seed (calcium, iron, magnesium) are real, but at a 2 g serving they are a rounding error beside ordinary foods.

Toxicity Symptoms

At high intake

The defining toxicity is chronic and silent. Miller and colleagues at the University of Wisconsin reported in 1983 that estragole and its metabolite 1'-hydroxyestragole, already shown to cause liver tumors in male mice dosed only before weaning, also caused liver tumors in female mice fed estragole for 12 months (Cancer Research 43:1124). In the same assay, anethole was inactive. The HMPC derived its 0.05 mg a day guidance from a TD50 (the daily dose giving tumors in half the animals) of 51.8 mg/kg, divided by 50,000 and scaled to a 50 kg adult, the approach used for mutagenic impurities under ICH M7. In 2026, Ackermann and colleagues detected the main estragole DNA adduct in 75 percent of 40 human liver samples from donors without liver disease (above the limit of quantification in 35 percent), at levels they judged well below those that trigger mutations in cell and rodent models; the donors' fennel intake was unknown. Acute toxicity at tea amounts is not the issue; at oil amounts, seizures are.

Not everyone reads these data as alarming. Van den Berg's 2014 margin-of-exposure analysis found adult daily use of one cup a low priority for risk management and children's use a priority, but estimated margins roughly three orders of magnitude higher when use was limited to 1 to 2 weeks. Gori and colleagues argued in 2012 that other substances in a fennel infusion blunt estragole's activation, and Ackermann's group found fewer adducts than expected from a bitter fennel preparation in liver cells. EFSA's 2025 draft nonetheless said it could not establish a safe level of exposure, and placed fennel infusions in infants and young children, and food supplements with detectable estragole in all population groups, under the principle that genotoxic carcinogens should not be deliberately added to food.

Signs to reduce or stop

• Any breast budding in a young girl, or breast enlargement in a boy, while fennel tea is being given

• In a breastfed baby whose mother drinks fennel-containing tea: sleepiness, poor suck, vomiting, weak cry, floppiness or poor weight gain

• A seizure, or new confusion, after any product containing fennel oil

• Hives, wheeze or lip swelling

• Digestive symptoms persisting past the 2-week adult limit

General note

At culinary amounts, fennel's hazards are allergy and little else. The concerns in this issue scale with dose, duration and age: daily medicinal tea, for months, in the youngest children and in women during pregnancy and breastfeeding.

How Fennel Works

Fennel's three relevant actions run through three different molecules, and only one of them is the reason people buy it.

Estragole: activation in the liver

Estragole itself is not the problem; its metabolites are. As Ackermann's group describes the pathway, liver enzymes CYP1A2 and CYP2A6 hydroxylate estragole to 1'-hydroxyestragole, and sulfotransferases SULT1A1 and SULT1C2 then attach a sulfate to form 1'-sulfooxyestragole. That ester is unstable and releases a reactive ion that binds DNA, mainly at guanine. In their 40 human liver samples, adduct levels tracked SULT1A1 protein, not CYP1A2, which points to the sulfation step as the one that sets individual susceptibility. Miller's finding that mice dosed before weaning developed liver tumors is one reason the young are treated as a sensitive group, although the author found no study measuring these enzymes in human infants given fennel.

Anethole: estrogen-like activity

Albert-Puleo reviewed fennel and anise as estrogenic agents in the Journal of Ethnopharmacology in 1980, noting their long reputation for increasing milk, promoting menstruation and easing birth, and proposed that polymers of anethole (dianethole, photoanethole) rather than anethole itself might carry the activity. The rodent data summarized by the HMPC are consistent with an estrogen-like effect: an acetone extract of fennel produced dose-dependent estrous induction and heavier mammary glands and uteri in female rats (Malini and colleagues, 1985), and trans-anethole increased uterine weight in immature female rats (Dhar, 1995). The immature-rat finding is the one that maps most directly onto the human premature thelarche reports. The author found no human study measuring an estrogenic endpoint after fennel tea.

Fenchone and the volatile oil: gut and nerve effects

The colic rationale is spasmolytic: Alexandrovich's group cited earlier work showing fennel seed oil reduced intestinal spasm and increased small intestine motility. The evidence is thin and partly contradictory, since Capasso's mouse study found the fennel extract in ColiMil did not alter upper gut transit. The same volatile ketones that are credited with relaxing smooth muscle, fenchone among them, are the ones Burkhard's group linked to seizures at essential oil doses.

What is not known

The concentration of estragole, anethole or fenchone in an infant's blood after a cup of fennel tea, or in breast milk after a mother's 3 to 5 cups of a nursing tea. Anethole has been detected in milk after a 100 mg dose in 18 women (per LactMed). EFSA's draft notes that estragole and related compounds can cross the placenta, form DNA adducts in the fetus and appear in breast milk, and cites mouse data showing tumors in exposed offspring.

Synergistic Supplements

No combination involving fennel has been shown to work better than its parts in a trial designed to test that. The combinations that matter are the ones a buyer will meet.

• Chamomile and lemon balm (ColiMil). The best infant result in this issue came from this three-herb extract, and the mouse work suggests the other two herbs carried the effect on gut transit.

• Anise, coriander and fenugreek (Mother's Milk and similar nursing teas). These are combinations by tradition, not by evidence; the only randomized trial of Mother's Milk was a safety study, not an efficacy study. Fenugreek has its own issue in this archive.

• Licorice, vervain, chamomile and balm-mint (the Weizman tea). A five-herb infant tea, licorice included.

The opposite of synergy: stacking estragole

Anise and star anise teas, basil (including pesto eaten daily) and tarragon add estragole from the same metabolic pathway. Two "tummy" teas, or a nursing tea plus a fennel tea, double the dose no label totals. Ackermann's group noted a possible offsetting effect, since anethole and estragole may compete for the same activating enzymes, but that is a cell culture observation, not a reason to combine products.

Interactions & What NOT to Take

Ciprofloxacin and other chelating antibiotics

Zhu, Wong and Li (Journal of Pharmacy and Pharmacology 1999;51:1391) gave male rats 20 mg/kg oral ciprofloxacin with or without an aqueous fennel extract (2 g of herb per kg), five rats per group. With fennel, peak plasma concentration fell 83 percent, area under the curve 48 percent and urinary recovery 43 percent; relative bioavailability was 0.52, and the half-life rose from 2.0 to 5.2 hours. The authors found no organic fennel constituent responsible and pointed instead to 13 mg/g of metal cations in the extract, which can chelate the antibiotic. Levofloxacin, moxifloxacin, doxycycline and other drugs that bind metal ions in the gut would be expected to behave the same way, an inference no human study has tested. If both are used, take them apart, as the authors advised; no human study has defined the gap.

Antiepileptic drugs

The Moroccan seizure case occurred despite lamotrigine. Its authors advised that people with epilepsy avoid fennel essential oil and that products containing it carry a seizure warning.

Estrogen-related drugs

Tamoxifen, aromatase inhibitors (anastrozole, letrozole), hormonal contraceptives and menopausal estrogen. The author found no human interaction study for any of them; the caution rests on fennel's estrogenic activity in animals and the thelarche reports.

Drug metabolism

Rahimi and Ardekani's 2012 review cites fennel extract as an inhibitor of CYP3A4 in laboratory work; CYP450 interactions are covered elsewhere in this batch, and no human study with a named CYP3A4 drug was found.

What not to give together

A gripe water containing fennel, a fennel tea and a breastfeeding mother's fennel-based nursing tea are three routes to the same compounds in one baby. Fennel essential oil should not be added to any of them.

Quality, Testing & Adulteration

Essential oil fraud, measured

Murphy and colleagues (Plants 2024;13:214) bought 30 commercial fennel, anise and star anise oils and tested them by gas chromatography and carbon and hydrogen isotope ratios. Eight of 30 (27 percent) were adulterated. One "fennel" oil was 43.2 percent triethyl citrate, a diluent. Another lacked fenchone, fennel's marker, carried star anise markers and was 35.4 percent capryl palmitate. A third showed the carbon isotope signature of synthetic anethole. A 2026 study in the Journal of Food Science (Liu and colleagues) built electronic-nose and GC-MS models to catch fennel oil cut with anise, dill, caraway or cumin oil, reporting 100 percent classification accuracy for samples more than 30 percent adulterated.

Baby tea, tested

The German consumer magazine Öko-Test rated Dr. Kottas Bio-Baby-Tee "ungenügend" (inadequate) in 2025 (Spezial Baby 2025) for estragole and pyrrolizidine alkaloids, plant toxins that enter teas through weed contamination. The maker replaced the fennel with caraway fruit, and a December 2025 retest found neither contaminant detectable. Öko-Test still criticized an age recommendation below 4 months and called for an estragole limit.

What certification marks cover

USP and NSF verification asks whether the ingredients and amounts on a label are actually in the product, whether contaminants stay under set limits, and whether the plant follows good manufacturing practice. A fennel tea label declares no estragole figure, so no certification can test it against one.

What a certificate of analysis should show

Species and variety (F. vulgare var. vulgare or var. dulce), whole or cut fruit, essential oil content against the pharmacopeial 40 mL/kg (bitter) or 20 mL/kg (sweet) minimum, a GC profile giving anethole, fenchone and estragole as percentages of the oil, ideally estragole in µg per liter of a standard infusion, and screens for pyrrolizidine alkaloids, pesticides and heavy metals. For an oil, fenchone should be present, diluents such as triethyl citrate absent, and a carbon isotope result available.

Reading the box yourself

• Whole seed or cut? Whole fruit releases about a third as much estragole into tea.

• Bitter or sweet? Bitter carries more oil and a higher estragole range. If the label does not say, ask.

• Grams per bag, and cups per day. Multiply them and compare with the EU's 4.5 g adult daily figure.

• An age statement. Any fennel product directed to a child under 4 is outside the EU monograph.

• A duration. A label with no time limit has dropped the EU's 2-week adult ceiling.

Special Considerations

Where the trial preparations belong

Listed here so none reads as a direction. Infant colic: a fennel seed oil emulsion of unstated concentration (Alexandrovich 2003); ColiMil twice daily for 1 week (Savino 2005); a five-herb tea (Weizman 1993). Dysmenorrhea: a fennel extract for 2 months (Modaress Nejad 2006); one 30 mg soft capsule every 4 hours from 3 days before menstruation to day 5, for 3 cycles (Ghodsi 2014). Lactation: 3 g of powdered fennel daily for 15 days, uncontrolled; a syrup containing 3 g of fennel. Polycystic ovary syndrome: fennel infusion plus dry cupping for 6 months against metformin in 61 women (Mokaberinejad 2019), a topic named here only.

How the European position moved

• November 2005: the HMPC's first estragole statement (EMEA/HMPC/137212/2005) judged short-term adult use at recommended doses not a significant cancer risk and asked that exposure in young children and in pregnant and breastfeeding women be kept to a minimum. It set no number.

• July 2007: the sweet fennel monograph (EMEA/HMPC/263293/2006) did not recommend use under 4, and called estragole's genotoxic risk not relevant "due to the small amount present in herbal infusions."

• 22 September 2021: Revision 1 of the estragole statement, after drafts in 2014 and 2019, set guidance values of 50 µg a day for adults and 1.0 µg/kg a day for children, framed oral use as short term, a maximum of 14 days, and said exposure should be "as low as practically achievable."

• 31 January 2024: the bitter fennel monograph revision wrote those values into fennel's own posology.

• July 2025: after Germany's Federal Institute for Risk Assessment raised concerns about fennel preparations for infants and young children, EFSA released its draft opinion for consultation. The author found no final version as of this issue.

Lactation, and a label that contradicts the monograph

The EU monograph does not recommend fennel during lactation. Mother's Milk states that it "is intended for use when nursing." The two texts answer to different legal systems, and only the European one addresses estragole. The pattern is not American: a 2026 analysis of 51 lactation teas sold online in Türkiye (Muslu and Korkmaz, Breastfeeding Medicine) found fennel in 94.1 percent and lactation claims on 98.0 percent.

Research Status & Evidence Quality

Tier 1, regulatory assessments

The HMPC estragole statement (2021) and bitter and sweet fennel monographs (2024); EFSA's 2025 draft. Traditional-use approvals, not efficacy findings.

Tier 2, randomized trials with positive results

Dysmenorrhea (multiple small Iranian trials and two 2020 to 2021 meta-analyses, one with high heterogeneity against placebo, neither finding a difference from NSAIDs); infant colic (three trials of three different preparations, 68 to 125 infants each); one galactagogue tea trial in 66 mothers.

Tier 3, safety trials and case reports

The 60-mother Mother's Milk safety trial; two premature thelarche reports (2008, 2014); two newborns affected through breast milk (1994); one seizure with fennel oil (2011).

Tier 4, exposure measurements

Estragole in teas (Raffo 2011; van den Berg 2014; Mihats 2017) and DNA adducts in human liver tissue (Ackermann 2026).

Tier 5, animal and in vitro

Liver tumors in mice (Miller 1983), estrogenic effects in rats, the ciprofloxacin interaction in rats, gut motility in mice.

Research Limitations

• The author found no trial of a plain retail fennel tea in infants.

• The author found no human epidemiological study of fennel tea and cancer; the hazard estimate is extrapolated from rodent bioassays and adduct data.

• No pharmacokinetic study of estragole or anethole in infants or in breast milk after real tea consumption.

• Colic and dysmenorrhea trials are small, short and mostly single-country; none measured estragole in the product given.

Summary & Key Takeaways

Bottom Line

Fennel is a reasonable short-term adult remedy for mild bloating and menstrual cramps, with traditional-use backing in the EU and small trials for cramps. Its most famous uses, soothing babies and boosting milk, are the ones Europe's medicines regulator advises against, because the fruit carries estragole, a genotoxic carcinogen in rodents, and measured fennel teas deliver it in amounts above that regulator's guidance values. The US nursing and fennel teas reviewed here state grams per bag and cups per day, and nothing about age, duration or estragole.

Key Safety Points

• No fennel tea for children under 4, per the EU monograph since 2007.

• Not recommended in pregnancy or breastfeeding under the 2024 monograph; EFSA's 2025 draft warns of possible risk to the unborn child and newborn.

• Two case reports link fennel to premature breast development in young girls; the reported case regressed after the tea stopped.

• Fennel essential oil is a convulsant at high doses and is never for oral use or for infants.

• Fennel cut the absorption of ciprofloxacin by about half in rats.

• Whole fruit, no squeezing, and no more than 2 weeks reduce estragole exposure for adults who use it.

Special Note

In 2007 Europe's herbal committee judged the estragole in fennel tea too small to matter at the doses it listed. By 2024 the same committee had written an estragole ceiling into fennel's own posology. Measurements made in between showed some single cups of commercial fennel tea exceeding the adult daily guidance tenfold. The baby and nursing tea listings reviewed for this issue still say nothing about it.

Forwarded this, or reading it on the web? to get the next breakdown.

Researched and drafted with AI assistance. Every claim verified against primary sources and human-reviewed before publication. Last reviewed: October 26, 2026. Corrections: reply to any issue.

This issue is for education only and is not medical advice. If you are pregnant, breastfeeding, caring for an infant, taking medication or being treated for a medical condition, check with a clinician before using fennel as a remedy.